After cancer, taking time to rest and travel can create space to heal, reconnect and remember that life is about more than simply surviving.
|Articles|October 8, 2022
Genderless Breast Cancer Research
Advertisement
Breast Cancer is genderless, but yet it is still often thought to be exclusively female. In this article, Rod Ritchie shares how the need for further research is important to help eliminate the gap in treatment outcomes.
Advertisement
Related to this article
Dr. Dina Khalaf explains the ASCERTAIN-V, MyeloMATCH MM1MDS-A01 and HOVON 181 trials and what patients with AML or MDS should ask before enrolling.
Children with diffuse midline glioma who took Keppra lived a median of 20.96 months, compared with 9.92 months for those who did not, a new study found.
A phase 1 trial treated 15 patients with breast cancer that spread to the spinal fluid using a vaccine made from their own immune cells. One patient is now more than three years from diagnosis.
Deborah A. McDowell of OAW explains how patients can prepare for hair loss before chemotherapy starts.
FDA approves an updated Ibtrozi label for locally advanced or metastatic ROS1-positive NSCLC, reflecting nearly four years of response data.
Gentle movement during cancer treatment can help maintain strength, mobility and balance. Follow Jennifer Tipton’s simple exercises to keep your body moving.
At three years, 69% of patients treated with Imfinzi and chemotherapy around surgery were alive, compared with 62% of patients treated with chemotherapy alone.
Advertisement
Advertisement